Assessment of the estrogen and progesterone receptor status of meningiomas. A preliminary study of 10 cases
Oddi, G.; Rebeck, L.; Bruni, P.
Minerva Medica 80(5): 487-490
1989
ISSN/ISBN: 0026-4806 PMID: 2664572 Document Number: 335429
Ten cases of intracranial meningiomas in patient who differed by age, sex and histological characteristics of the lesion have been considered for the purpose of evaluating the lesion's receptor capacity and the changes in it with the above variations. Receptors were found and they varied with age and histological features.
Document emailed within 1 workday
Related Documents
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Sartin, E.A.; Barnes, S.; Kwapien, R.P.; Wolfe, L.G. 1992: Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs American Journal of Veterinary Research 53(11): 2196-2200
Ellinidi, V.N.; Anikeeva, N.V.; Goncharova, O.A.; Krasnozhon, D.A. 2005: Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status Voprosy Onkologii 51(2): 197-199
Gaglio, A.; Iraldi, G.R.; Zai, G.; Zanin, A. 1987: Carcinoma of the colon and rectum: comparison of grading, estrogen and progesterone receptor status and proliferative activity Pathologica 79: 1059-1060
Nardelli, G.B.; Lamaina, V.; Siliotti, F. 1986: Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report) European Journal of Gynaecological Oncology 7(3): 151-158
Shen, X.Q. 1992: Comparative study of single-point method and multipoint method in the measurement of estrogen receptor and progesterone receptor in breast cancer Zhonghua Zhong Liu Za Zhi 14(2): 112-115
Swanson, S.M.; Christov, K. 2003: Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency Anticancer Research 23(4): 3207-3213
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Wanless, C.; Barker, S.; Puddefoot, J.R.; Panahy, C.; Goode, A.W.; Vinson, G.P.; Phillips, I.R. 1991: Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor Anticancer Research 11(1): 139-142
Segreti, E.M.; Novotny, D.B.; Soper, J.T.; Mutch, D.G.; Creasman, W.T.; McCarty, K.S. 1989: Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor Obstetrics and Gynecology 73(5 Pt 1): 780-785
Strik, H.M.; Strobelt, I.; Pietsch-Breitfeld, B.; Iglesias-Rozas, J.R.; Will, B.; Meyermann, R. 2002: The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas In Vivo 16(4): 265-270
Giuliani, S.; Leonardi, E.; Aldovini, D.; Bernardi, D.; Pellegrini, M.; Soli, F.; Ferro, A.; Dalla Palma, P.; Decarli, N.; Barbareschi, M. 2012: Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy Pathologica 104(3): 93-97
Wu, X.; Liu, X.; Jin, X.; Xu, X. 2014: Effects of levonorgestrel intrauterine system on the expressions of estrogen receptor, progesterone receptor and insulin-like growth factor-1 Zhonghua Yi Xue Za Zhi 94(35): 2763-2765
Berger, U.; Wilson, P.; Thethi, S.; McClelland, R.A.; Greene, G.L.; Coombes, R.C. 1989: Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors Cancer Research 49(18): 5176-5179
Saez, S.; Martin, P.M.; Chouvet, C.D. 1978: Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels Cancer Research 38(10): 3468-3473
Avci, N.; Deligonul, A.; Tolunay, S.; Cubukcu, E.; Fatih Olmez, O.; Ulas, A.; Hartavi, M.; Kurt, E.; Evrensel, T. 2015: Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 45-49
Fondo, E.Y.; Menendez-Botet, C.J.; Schwartz, M.K.; Whitmore, W.F. 1981: Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report Journal of the National Medical Association 73(3): 261-266
Huang, Y.; Jensen, J.T.; Brache, V.; Cochon, L.; Williams, A.; Miranda, M.-J.é; Croxatto, H.; Kumar, N.; Sussman, H.; Hoskin, E.; Plagianos, M.; Roberts, K.; Merkatz, R.; Blithe, D.; Sitruk-Ware, R. 2014: A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception Contraception 90(6): 565-574
Echeverría, O.M.; Thampan, R.V.; Juárez-Chavero, S.; Hernández-Pérez, A.D.; Ortiz, R.; Vázquez-Nin, G.H. 2005: Immunocytochemical study of estrogen receptor activation factor (E-RAF) and the proteins that interact with nuclear estrogen receptor II (nER II) in epithelial endometrial cells, in the presence and in the absence of estradiol European Journal of Histochemistry: Ejh 49(1): 67-74